Variables | All STEMIs | In-hospital LVEF >35% | In-hospital LVEF ≤35% | p Value* |
---|---|---|---|---|
N | 3902 | 2904 | 332 | |
Male, n (%) | 2725 (70) | 2041 (70) | 244 (73) | 0.46 |
Age, years (range) | 65 (23–99) | 63±13 | 65±14 | 0.01 |
QRS duration ≥120 ms, n (%) | 98 (3) | 67 (2) | 31 (9) | <0.01 |
Previous MI—n (%) | 547 (14) | 361 (12) | 65 (20) | 0.01 |
Previous angina—n (%) | 569 (15) | 382 (13) | 55 (17) | 0.36 |
Previous PCI, n (%) | 233 (6.0) | 169 (6) | 22 (7) | 0.90 |
Previous CABG, n (%) | 106 (2.7) | 71 (2) | 11 (3) | 0.77 |
Hypertension—n (%) | 1657 (43) | 1210 (42) | 139 (42) | 0.97 |
Hypercholesterolaemia, n (%) | 1338 (34) | 1024 (35) | 105 (32) | 0.58 |
Peripheral vascular disease, n (%) | 135 (3.5) | 108 (4) | 23 (7) | 0.04 |
Cerebrovascular disease, n (%) | 185 (4.7) | 108 (4) | 23 (7) | 0.04 |
Chronic renal failure, n (%) | 38 (1.0) | 18 (1) | 7 (2) | 0.03 |
Heart failure, n (%) | 30 (0.8) | 7 (0.0) | 12 (4) | <0.01 |
Diabetes, n (%) | 433 (11) | 295 (10) | 42 (13) | 0.01 |
*Comparison of patients with LVEF ≤35% versus patients with LVEF >35%.
CABG, coronary artery bypass graft surgery; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention; STEMIs, ST-elevation myocardial infarction. Bold text are key parts of the guidance.